Enterprise Financial Services Corp (EFSC)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-97
Closed -$4K – 552
2021
Q2
$4K Hold
97
– – ﹤0.01% 966
2021
Q1
$3K Hold
97
– – ﹤0.01% 1044
2020
Q4
$3K Sell
97
-69
-42% -$1.41K ﹤0.01% 982
2020
Q3
$3K Sell
166
-66
-28% -$1.38K ﹤0.01% 951
2020
Q2
$5K Buy
232
+163
+236% +$2.92K ﹤0.01% 839
2020
Q1
$1K Buy
+69
New +$1.93K ﹤0.01% 1129
2019
Q2
– Sell
-57
Closed -$4K – 1176
2019
Q1
$4K Buy
+57
New +$3.82K ﹤0.01% 941
2018
Q4
– Sell
-85
Closed -$10K – 996
2018
Q3
$10K Buy
85
+57
+204% +$6.43K 0.01% 588
2018
Q2
$4K Hold
28
– – ﹤0.01% 756
2018
Q1
$3K Hold
28
– – ﹤0.01% 784
2017
Q4
$3K Buy
+28
New +$2.79K ﹤0.01% 759

Other funds holding CLB

Enterprise Financial Services Corp (EFSC)'s CLB Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 97 shares — an estimated $4K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CLB in Q4 2017 and held it in 11 quarters. The position peaked at $10K in Q3 2018. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 97 Core Laboratories shares in Q3 2021, an estimated $4K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Core Laboratories in Q4 2017 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Core Laboratories position peaked at $10K in Q3 2018.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.